In honor of March Madness, the Motley Fool's health-care team assembled their own bracket consisting of the 16 largest and best pharmaceutical and biotech stocks on the market. The series kicks off with a tough match up between Abbott (ABT -1.16%), the medical device giant that recently spun-off its pharmaceutical division, and diabetes giant Novo Nordisk (NVO -0.47%). To learn the bull and bear cases for each stock -- and to see which stock will move on to the Elite Eight -- watch the video below.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.